Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Panza

Showing results (121-130 of 404) with videos related to

Pageof 41
Sort By:
Expert Opinion on Investigational Drugs|January 13, 2011
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?Bruno P Imbimbo, Francesco Panza, Vincenza Frisardi, et al.
Immunotherapy|November 25, 2010
Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's diseaseFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Ageing Research Reviews|August 1, 2009
Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanismsVincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, et al.
Experimental Gerontology|July 18, 2006
Serum total cholesterol as a biomarker for Alzheimer's disease: mid-life or late-life determinations?Francesco Panza, Cristiano Capurso, Alessia D'Introno, et al.
Neurobiology of Aging|November 1, 2005
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on AgingVincenzo Solfrizzi, Anna Maria Colacicco, Alessia D'Introno, et al.
Expert Review of Neurotherapeutics|April 12, 2019
Disease-modifying therapies for tauopathies: agents in the pipelineFrancesco Panza, Bruno P Imbimbo, Madia Lozupone, et al.
Journal of Rehabilitation Medicine|September 30, 2010
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case reportAndrea Santamato, Francesco Panza, Maurizio Ranieri, et al.
Journal of Alzheimer'S Disease : JAD|April 28, 2010
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?Vincenza Frisardi, Vincenzo Solfrizzi, Cristiano Capurso, et al.
Archives of Neurology|July 15, 2009
Mediterranean dietary pattern, mild cognitive impairment, and progression to dementiaVincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, et al.
Recenti Progressi in Medicina|October 3, 2002
[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism]Francesco Panza, Vincenzo Solfrizzi, Alessia D'Introno, et al.
Pageof 41

Showing results (121-130 of 404) with videos related to

Sort By:
Pageof 41
Expert Opinion on Investigational Drugs|January 13, 2011
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?Bruno P Imbimbo, Francesco Panza, Vincenza Frisardi, et al.
Immunotherapy|November 25, 2010
Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's diseaseFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Ageing Research Reviews|August 1, 2009
Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanismsVincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, et al.
Experimental Gerontology|July 18, 2006
Serum total cholesterol as a biomarker for Alzheimer's disease: mid-life or late-life determinations?Francesco Panza, Cristiano Capurso, Alessia D'Introno, et al.
Neurobiology of Aging|November 1, 2005
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on AgingVincenzo Solfrizzi, Anna Maria Colacicco, Alessia D'Introno, et al.
Expert Review of Neurotherapeutics|April 12, 2019
Disease-modifying therapies for tauopathies: agents in the pipelineFrancesco Panza, Bruno P Imbimbo, Madia Lozupone, et al.
Journal of Rehabilitation Medicine|September 30, 2010
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case reportAndrea Santamato, Francesco Panza, Maurizio Ranieri, et al.
Journal of Alzheimer'S Disease : JAD|April 28, 2010
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?Vincenza Frisardi, Vincenzo Solfrizzi, Cristiano Capurso, et al.
Archives of Neurology|July 15, 2009
Mediterranean dietary pattern, mild cognitive impairment, and progression to dementiaVincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, et al.
Recenti Progressi in Medicina|October 3, 2002
[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism]Francesco Panza, Vincenzo Solfrizzi, Alessia D'Introno, et al.
Pageof 41